The Fabry disease-causing mutation, GLA IVS4+919G>A, originated in Mainland China more than 800 years ago

Abstract

The Fabry disease-causing mutation, the GLA IVS4+919G>A (designated GLA IVS4), is very prevalent in patients with hypertrophic cardiomyopathy in Taiwan. This X-linked mutation has also been found in patients in Kyushu, Japan and Southeast Asia. To investigate the age and the possible ancestral origin of this mutation, a total of 33 male patients with the GLA IVS4+919G>A mutation, born in Taiwan, Japan, Singapore, Malaysia, Vietnam, and the Fujian and Guangdong provinces of China, were studied. Peripheral bloods were collected, and the Ilumina Infinium CoreExome-24 microarray was used for dense genotyping. A mutation-carrying haplotype was discovered which was shared by all 33 patients. This haplotype does not exist in 15 healthy persons without the mutation. Rather, a wide diversity of haplotypes was found in the vicinity of the mutation site, supporting the existence of a single founder of the GLA IVS4 mutation. The age of the founder mutation was estimated by the lengths of the mutation-carrying haplotypes based on the linkage-disequilibrium decay theory. The first, second, and third quartile of the age estimates are 800.7, 922.6, and 1068.4 years, respectively. We concluded that the GLA IVS4+919G>A mutation originated from a single mutational event that occurred in a Chinese chromosome more than 800 years ago.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. 1.

    Desnick RJ. Fabry disease (α-galactosidase A deficiency). In: Encyclopedia of genetics. Berkeley: Elsevier; 2001. p. 681.

  2. 2.

    Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5:30. https://doi.org/10.1186/1750-1172-5-30.

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Desnick RJ. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138:338. https://doi.org/10.7326/0003-4819-138-4-200302180-00014.

    Article  PubMed  Google Scholar 

  4. 4.

    Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype1. Kidney Int. 2003;64:801–7. https://doi.org/10.1046/j.1523-1755.2003.00160.x.

    Article  PubMed  Google Scholar 

  5. 5.

    Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry’s disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288–93. https://doi.org/10.1056/nejm199508033330504.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Wv Scheidt, Eng CM, Fitzmaurice TF, Erdmann E, Hübner G, EGJ Olsen, et al. An atypical variant of Fabry’s disease with manifestations confined to the myocardium. N Engl J Med. 1991;324:395–9. https://doi.org/10.1056/nejm199102073240607.

    Article  Google Scholar 

  7. 7.

    Desnick RJ, Brady RO. Fabry disease in childhood. J Pediatrics. 2004;144:S20–S6. https://doi.org/10.1016/j.jpeds.2004.01.051.

    Article  Google Scholar 

  8. 8.

    Lin H-Y, Chong K-W, Hsu J-H, Yu H-C, Shih C-C, Huang C-H, et al. High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet. 2009;2:450–6. https://doi.org/10.1161/circgenetics.109.862920.

    Article  PubMed  Google Scholar 

  9. 9.

    Hsu T-R, Hung S-C, Chang F-P, Yu W-C, Sung S-H, Hsu C-L, et al. Later onset Fabry disease, cardiac damage progress in silence. J Am Coll Cardiol. 2016;68:2554–63. https://doi.org/10.1016/j.jacc.2016.09.943.

    Article  PubMed  Google Scholar 

  10. 10.

    Ishii S, Nakao S, Minamikawa-Tachino R, Desnick RJ, Fan J-Q. Alternative splicing in the α-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am J Hum Genet. 2002;70:994–1002. https://doi.org/10.1086/339431.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Chang W-H, Niu D-M, Lu C-Y, Lin S-Y, Liu T-C, Chang J-G. Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease. PLOS One. 2017;12:e0175929. https://doi.org/10.1371/journal.pone.0175929.

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Lin H-Y, Liu H-C, Huang Y-H, Liao H-C, Hsu T-R, Shen C-I, et al. Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A). BMJ Open. 2013;3:e003146. https://doi.org/10.1136/bmjopen-2013-003146.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Niu D-M, Yu W-C, Hsu T-R, Chang F-P, Sung S-H, Chu T-H. When is the best time to start enzyme replacement therapy in patients with cardiac-type Fabry disease? Experience from Taiwan, an area highly prevalent in this cardiac phenotype. Mol Genet Metab. 2015;114:S87–S8. https://doi.org/10.1016/j.ymgme.2014.12.194.

    Article  Google Scholar 

  14. 14.

    Gandolfo LC, Bahlo M, Speed TP. Dating rare mutations from small samples with dense marker data. Genetics. 2014;197:1315–27. https://doi.org/10.1534/genetics.114.164616.

    Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Efron B. Bootstrap methods: another look at the Jackknife, Springer series in statistics. New York: Springer; 1992. p. 569–93.

    Google Scholar 

  16. 16.

    Carriço JA, Crochemore M, Francisco AP, Pissis SP, Ribeiro-Gonçalves B, Vaz C. Fast phylogenetic inference from typing data. Algorithms Mol Biol. 2018;13. https://doi.org/10.1186/s13015-017-0119-7.

  17. 17.

    Altshuler D, Gibbs R, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467:52–8.

    CAS  Article  Google Scholar 

  18. 18.

    Kanzawa-Kiriyama H, Jinam TA, Kawai Y, Sato T, Hosomichi K, Tajima A, et al. Late Jomon male and female genome sequences from the Funadomari site in Hokkaido, Japan. Anthropological Sci. 2019;127:83–108. https://doi.org/10.1537/ase.190415.

    Article  Google Scholar 

  19. 19.

    Choi J-H, Lee BH, Heo SH, Kim G-H, Kim Y-M, Kim D-S, et al. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey. Medicine. 2017;96:e7387. https://doi.org/10.1097/md.0000000000007387.

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Tadaka S, Katsuoka F, Ueki M, Kojima K, Makino S, Saito S, et al. 3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome. Hum Genome Var. 2019;6. https://doi.org/10.1038/s41439-019-0059-5.

  21. 21.

    Dreyer EL. Japanese piracy in Ming China during the 16th Century. By Kwan-Wai So. East Lansing: Michigan State University Press, 1975. x, 254 pp. J Asian Stud. 1976;36:129–30. https://doi.org/10.1017/s002191180007902x.

Download references

Acknowledgements

The authors would like to thank Wen-Ya Ko for his professional advices in population genetics, as well as the journal reviewer #2 for the comprehensive guidance in the presentation of the manuscript.

Funding

This work was partly supported by the Ministry of Science and Technology, Taiwan (grant number 108-2321-B-075-003).

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Kimitoshi Nakamura or Dau-Ming Niu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liang, K., Lu, Y., Niu, C. et al. The Fabry disease-causing mutation, GLA IVS4+919G>A, originated in Mainland China more than 800 years ago. J Hum Genet 65, 619–625 (2020). https://doi.org/10.1038/s10038-020-0745-7

Download citation